hapabapa/iStock Editorial through Getty Photographs
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, often known as Victoza, from a listing of medicine which can be allowed to be compounded.
In a Citizen Petition posted on Rules.gov, Novo Nordisk (NVO) famous
